CVS Health price target lowered to $58 from $68 at RBC Capital
RBC Capital analyst Ben Hendrix lowered the firm’s price target on CVS Health (CVS) to $58 from $68 and keeps an Outperform rating on the ...
RBC Capital Reaffirms Their Buy Rating on CVS Health (CVS)
RBC Capital analyst Ben Hendrix maintained a Buy rating on CVS Health (CVS – Research Report) yesterday and set a price target of $58.00.
Hosted on MSN2d
Savvy Senior: Best pill boxes and medication management tools
Can you recommend some good pill boxes and medication reminding devices? I’ve recently started taking several new prescription medications along with some vitamins I normally take and need to get a ...